Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscle, Skeletal | 22 | 2024 | 449 | 4.600 |
Why?
|
| Annexin A6 | 6 | 2022 | 10 | 2.360 |
Why?
|
| Muscle Proteins | 8 | 2021 | 132 | 2.200 |
Why?
|
| Muscular Dystrophies | 6 | 2024 | 54 | 2.160 |
Why?
|
| Cell Membrane | 9 | 2021 | 666 | 2.090 |
Why?
|
| Membrane Proteins | 11 | 2021 | 1196 | 2.050 |
Why?
|
| Muscular Dystrophy, Duchenne | 8 | 2024 | 30 | 2.040 |
Why?
|
| Muscular Dystrophy, Animal | 8 | 2019 | 21 | 1.940 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 45 | 1.890 |
Why?
|
| Immunoglobulin G | 6 | 2023 | 456 | 1.830 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 5 | 2024 | 14 | 1.480 |
Why?
|
| Calcium | 4 | 2022 | 1156 | 1.250 |
Why?
|
| Dysferlin | 5 | 2021 | 13 | 1.200 |
Why?
|
| Muscle Development | 6 | 2019 | 41 | 1.200 |
Why?
|
| Dried Blood Spot Testing | 3 | 2021 | 10 | 1.170 |
Why?
|
| Vesicular Transport Proteins | 3 | 2015 | 63 | 1.100 |
Why?
|
| Muscles | 3 | 2024 | 194 | 1.040 |
Why?
|
| Vaccines, Synthetic | 2 | 2021 | 55 | 1.010 |
Why?
|
| Sarcolemma | 10 | 2019 | 30 | 0.870 |
Why?
|
| Membrane Fusion | 3 | 2021 | 37 | 0.840 |
Why?
|
| Neuromuscular Diseases | 1 | 2021 | 30 | 0.820 |
Why?
|
| Excitation Contraction Coupling | 1 | 2021 | 5 | 0.820 |
Why?
|
| Mice | 25 | 2024 | 11352 | 0.810 |
Why?
|
| Serologic Tests | 2 | 2021 | 41 | 0.810 |
Why?
|
| Family Characteristics | 2 | 2022 | 48 | 0.810 |
Why?
|
| Annexins | 2 | 2022 | 6 | 0.800 |
Why?
|
| Animals | 34 | 2024 | 26582 | 0.770 |
Why?
|
| Pandemics | 5 | 2023 | 740 | 0.740 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2010 | 114 | 0.710 |
Why?
|
| Gene Editing | 1 | 2019 | 42 | 0.700 |
Why?
|
| Exons | 3 | 2019 | 450 | 0.690 |
Why?
|
| Spike Glycoprotein, Coronavirus | 5 | 2022 | 40 | 0.690 |
Why?
|
| Antibodies, Viral | 6 | 2022 | 293 | 0.670 |
Why?
|
| Health Personnel | 1 | 2020 | 202 | 0.640 |
Why?
|
| Myoblasts | 6 | 2015 | 31 | 0.630 |
Why?
|
| Sarcoglycans | 6 | 2019 | 13 | 0.610 |
Why?
|
| Muscle Cells | 1 | 2017 | 18 | 0.610 |
Why?
|
| Betacoronavirus | 1 | 2020 | 258 | 0.600 |
Why?
|
| Protein Transport | 8 | 2016 | 411 | 0.590 |
Why?
|
| Health | 1 | 2015 | 29 | 0.540 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.520 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.520 |
Why?
|
| Neutralization Tests | 4 | 2022 | 77 | 0.520 |
Why?
|
| Disease | 1 | 2015 | 90 | 0.510 |
Why?
|
| Muscular Diseases | 3 | 2023 | 63 | 0.490 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 9 | 0.490 |
Why?
|
| Dynamin II | 1 | 2014 | 15 | 0.490 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 5 | 0.490 |
Why?
|
| Glycerol | 1 | 2013 | 32 | 0.470 |
Why?
|
| Glucocorticoids | 4 | 2023 | 352 | 0.450 |
Why?
|
| Actins | 1 | 2016 | 451 | 0.450 |
Why?
|
| Fibrosis | 4 | 2023 | 203 | 0.440 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 112 | 0.440 |
Why?
|
| Mice, Knockout | 6 | 2024 | 1924 | 0.430 |
Why?
|
| Gene Expression | 3 | 2019 | 1284 | 0.410 |
Why?
|
| Disease Models, Animal | 6 | 2023 | 2232 | 0.400 |
Why?
|
| Antibody Formation | 2 | 2021 | 171 | 0.390 |
Why?
|
| Seroepidemiologic Studies | 2 | 2021 | 55 | 0.390 |
Why?
|
| RNA, Messenger | 3 | 2019 | 1981 | 0.380 |
Why?
|
| Mice, 129 Strain | 3 | 2021 | 55 | 0.380 |
Why?
|
| NFATC Transcription Factors | 1 | 2010 | 29 | 0.380 |
Why?
|
| Male | 15 | 2023 | 40965 | 0.380 |
Why?
|
| Myocytes, Cardiac | 5 | 2024 | 275 | 0.370 |
Why?
|
| Latent TGF-beta Binding Proteins | 2 | 2021 | 4 | 0.370 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2009 | 44 | 0.360 |
Why?
|
| DNA | 1 | 2015 | 1294 | 0.360 |
Why?
|
| Wound Healing | 4 | 2016 | 344 | 0.360 |
Why?
|
| Prednisone | 3 | 2019 | 258 | 0.350 |
Why?
|
| Female | 12 | 2023 | 44532 | 0.310 |
Why?
|
| Humans | 25 | 2024 | 86643 | 0.300 |
Why?
|
| Carrier Proteins | 3 | 2021 | 673 | 0.290 |
Why?
|
| Young Adult | 4 | 2021 | 5976 | 0.280 |
Why?
|
| Vaccination | 3 | 2023 | 254 | 0.270 |
Why?
|
| Regeneration | 3 | 2017 | 143 | 0.260 |
Why?
|
| Cells, Cultured | 6 | 2018 | 2818 | 0.260 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 104 | 0.250 |
Why?
|
| Immunoblotting | 2 | 2016 | 268 | 0.250 |
Why?
|
| Proteostasis | 1 | 2024 | 8 | 0.240 |
Why?
|
| Middle Aged | 6 | 2023 | 25028 | 0.240 |
Why?
|
| Mice, Inbred DBA | 6 | 2024 | 148 | 0.230 |
Why?
|
| Mice, Mutant Strains | 2 | 2016 | 229 | 0.220 |
Why?
|
| Adult | 5 | 2021 | 25648 | 0.220 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 302 | 0.220 |
Why?
|
| Mice, Inbred mdx | 4 | 2019 | 11 | 0.220 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2015 | 279 | 0.220 |
Why?
|
| Mice, Transgenic | 4 | 2022 | 1540 | 0.210 |
Why?
|
| Calcium-Binding Proteins | 2 | 2021 | 115 | 0.210 |
Why?
|
| Immunologic Tests | 1 | 2021 | 6 | 0.210 |
Why?
|
| Monocytes | 1 | 2023 | 214 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 2 | 2015 | 503 | 0.200 |
Why?
|
| Cardiomyopathies | 1 | 2024 | 240 | 0.200 |
Why?
|
| Drug Interactions | 1 | 2021 | 248 | 0.200 |
Why?
|
| Extracellular Vesicles | 1 | 2022 | 42 | 0.200 |
Why?
|
| Heart Diseases | 1 | 2023 | 290 | 0.190 |
Why?
|
| Genes, Modifier | 2 | 2017 | 5 | 0.190 |
Why?
|
| Steroids | 1 | 2021 | 177 | 0.190 |
Why?
|
| Muscle Contraction | 1 | 2021 | 283 | 0.190 |
Why?
|
| Mice, Inbred C57BL | 5 | 2016 | 3092 | 0.190 |
Why?
|
| Chicago | 2 | 2021 | 1379 | 0.180 |
Why?
|
| Lysosomes | 2 | 2010 | 104 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 376 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2021 | 301 | 0.170 |
Why?
|
| Myotonic Dystrophy | 1 | 2019 | 7 | 0.170 |
Why?
|
| MyoD Protein | 1 | 2019 | 15 | 0.170 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2019 | 1 | 0.170 |
Why?
|
| Signal Transduction | 1 | 2009 | 3241 | 0.170 |
Why?
|
| Point Mutation | 1 | 2019 | 246 | 0.170 |
Why?
|
| Sarcoglycanopathies | 1 | 2018 | 2 | 0.160 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 115 | 0.160 |
Why?
|
| Morpholinos | 1 | 2018 | 13 | 0.160 |
Why?
|
| Adolescent | 2 | 2021 | 8981 | 0.160 |
Why?
|
| Osteopontin | 1 | 2017 | 47 | 0.150 |
Why?
|
| Protein Binding | 4 | 2022 | 1456 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2019 | 1014 | 0.150 |
Why?
|
| Genetic Therapy | 2 | 2018 | 342 | 0.150 |
Why?
|
| Phospholipids | 1 | 2017 | 111 | 0.150 |
Why?
|
| Exosomes | 1 | 2017 | 50 | 0.140 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 1991 | 0.140 |
Why?
|
| Microscopy, Fluorescence | 2 | 2018 | 425 | 0.140 |
Why?
|
| Cell Communication | 1 | 2017 | 194 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2024 | 1565 | 0.140 |
Why?
|
| Dystrophin-Associated Protein Complex | 1 | 2015 | 3 | 0.140 |
Why?
|
| Electroporation | 1 | 2015 | 55 | 0.140 |
Why?
|
| Creatine Kinase | 1 | 2015 | 52 | 0.140 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2015 | 69 | 0.130 |
Why?
|
| Base Sequence | 1 | 2019 | 2330 | 0.130 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 144 | 0.130 |
Why?
|
| Plasmids | 1 | 2015 | 287 | 0.130 |
Why?
|
| Intracellular Space | 2 | 2014 | 38 | 0.130 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 268 | 0.130 |
Why?
|
| Protein Engineering | 1 | 2015 | 140 | 0.120 |
Why?
|
| Heterozygote | 1 | 2015 | 365 | 0.120 |
Why?
|
| Cohort Studies | 1 | 2021 | 2767 | 0.120 |
Why?
|
| Fluorescent Dyes | 1 | 2015 | 242 | 0.120 |
Why?
|
| Cell Adhesion | 1 | 2015 | 420 | 0.120 |
Why?
|
| Caveolin 3 | 1 | 2014 | 4 | 0.120 |
Why?
|
| HIV Infections | 1 | 2023 | 772 | 0.120 |
Why?
|
| Aged | 2 | 2021 | 18415 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 927 | 0.120 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 134 | 0.120 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 379 | 0.120 |
Why?
|
| Cell Survival | 1 | 2015 | 969 | 0.110 |
Why?
|
| Endosomes | 2 | 2010 | 75 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2014 | 193 | 0.110 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 232 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2017 | 534 | 0.110 |
Why?
|
| Dystrophin | 3 | 2019 | 21 | 0.100 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2010 | 5 | 0.100 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1920 | 0.100 |
Why?
|
| Cardiotoxins | 1 | 2010 | 3 | 0.100 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2009 | 4 | 0.090 |
Why?
|
| Myoblasts, Skeletal | 1 | 2009 | 3 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 2271 | 0.090 |
Why?
|
| Myofibrils | 1 | 2009 | 23 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2010 | 129 | 0.090 |
Why?
|
| Models, Animal | 1 | 2010 | 263 | 0.090 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.080 |
Why?
|
| Cell Line | 3 | 2019 | 2468 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 2357 | 0.080 |
Why?
|
| RNA Splicing | 2 | 2019 | 142 | 0.080 |
Why?
|
| Endocytosis | 1 | 2008 | 177 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2022 | 615 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 937 | 0.070 |
Why?
|
| Lamin Type A | 1 | 2006 | 24 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2006 | 579 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2024 | 133 | 0.060 |
Why?
|
| Quantitative Trait Loci | 2 | 2019 | 576 | 0.050 |
Why?
|
| Nuclear Proteins | 1 | 2006 | 696 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 39 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2024 | 227 | 0.050 |
Why?
|
| Vero Cells | 1 | 2022 | 100 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 212 | 0.050 |
Why?
|
| Antibodies, Blocking | 1 | 2021 | 21 | 0.050 |
Why?
|
| Immunoassay | 1 | 2021 | 92 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2022 | 498 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 736 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 295 | 0.050 |
Why?
|
| Pulse Therapy, Drug | 1 | 2019 | 1 | 0.050 |
Why?
|
| Anacardic Acids | 1 | 2019 | 1 | 0.050 |
Why?
|
| MEF2 Transcription Factors | 1 | 2019 | 9 | 0.050 |
Why?
|
| Residence Characteristics | 1 | 2021 | 197 | 0.050 |
Why?
|
| Histone Acetyltransferases | 1 | 2019 | 38 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2019 | 1351 | 0.040 |
Why?
|
| Metabolomics | 1 | 2019 | 68 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2019 | 93 | 0.040 |
Why?
|
| Epigenomics | 1 | 2019 | 100 | 0.040 |
Why?
|
| Disease Progression | 1 | 2023 | 1531 | 0.040 |
Why?
|
| Reading Frames | 1 | 2018 | 6 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 72 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2018 | 37 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2022 | 1538 | 0.040 |
Why?
|
| Annexin A1 | 1 | 2017 | 5 | 0.040 |
Why?
|
| Urine | 1 | 2018 | 90 | 0.040 |
Why?
|
| Transduction, Genetic | 1 | 2018 | 153 | 0.040 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2017 | 40 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2024 | 1458 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2019 | 894 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2019 | 276 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 104 | 0.040 |
Why?
|
| Muscular Atrophy | 1 | 2017 | 41 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2019 | 246 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2017 | 272 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2017 | 120 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 280 | 0.030 |
Why?
|
| Codon, Nonsense | 1 | 2015 | 41 | 0.030 |
Why?
|
| Mutation | 2 | 2018 | 3968 | 0.030 |
Why?
|
| Diaphragm | 1 | 2015 | 50 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 479 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2019 | 1074 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 916 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 82 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2018 | 729 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2015 | 205 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 2705 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 1621 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 2014 | 19 | 0.030 |
Why?
|
| Membranes | 1 | 2014 | 36 | 0.030 |
Why?
|
| Chromosomes, Mammalian | 1 | 2014 | 36 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 557 | 0.030 |
Why?
|
| Biomarkers | 1 | 2019 | 1718 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 193 | 0.030 |
Why?
|
| Organ Size | 1 | 2014 | 364 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2014 | 201 | 0.030 |
Why?
|
| Myocardium | 1 | 2015 | 529 | 0.030 |
Why?
|
| Time Factors | 1 | 2021 | 5210 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 488 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 599 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 547 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2014 | 760 | 0.020 |
Why?
|
| Transferrin | 1 | 2008 | 19 | 0.020 |
Why?
|
| Cell Fusion | 1 | 2008 | 39 | 0.020 |
Why?
|
| Child | 1 | 2019 | 6927 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2008 | 210 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2008 | 351 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2006 | 36 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2006 | 94 | 0.020 |
Why?
|
| Hydroxyproline | 1 | 2005 | 11 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 2062 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2008 | 1286 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 3030 | 0.010 |
Why?
|
| Motor Activity | 1 | 2005 | 327 | 0.010 |
Why?
|